Evidence map›Paper›PMID 11413192›Full record

ArticleThe Journal of experimental medicine2001

Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells.

C H Kim, L S Rott, I Clark-Lewis, D J Campbell, L Wu, E C Butcher

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 305 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

305 citing papers in PubMed, 1 synthesis or guideline pooled it, 617 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fibroblast diversity within human gut-associated lymphoid tissues.The Journal of experimental medicine · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Multimodal analysis definesbioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. CXCL13/CXCR5: a new target for pain treatment.International journal of surgery (London, England) · 2025
    Review

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

C H KimLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA. chkim@stanford.edu
L S Rott
I Clark-Lewis
D J Campbell
L Wu
E C Butcher
Stanford University · USMillennium Engineering and Integration (United States) · USUniversity of British Columbia · CAVA Palo Alto Health Care System · US

Funding

Intestinal Lymphocyte TraffickingR01AI047822 · NIAID · STANFORD UNIVERSITY · PI EUGENE C BUTCHER · 2001 to 2026
$4.7M
Intestinal Lymphocyte TraffickingR37AI047822 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2011 to 2020
$3.5M
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATIONR37GM037734 · NIGMS · STANFORD UNIVERSITY · PI BUTCHER, EUGENE C · 1999 to 2008
$2.8M
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATIONR01GM037734 · NIGMS · STANFORD UNIVERSITY · PI BUTCHER, EUGENE C · 1987 to 2017
$938k
CCR9 AND TECK IN INTESTINAL LYMPHOCYTE TRAFFICKINGR21AI047822 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BUTCHER, EUGENE C · 2000 to 2000
$258k
A4B7 INTEGRIN IN INTESTINAL INFLAMMATION AND IMMUNITYR01AI037832 · NIAID · STANFORD UNIVERSITY · PI BUTCHER, EUGENE C · 1995 to 1999
–
NIAID NIH HHS AI37832NIAID NIH HHS AI47822NIAID NIH HHS R01 AI047822NIAID NIH HHS R21 AI047822NIAID NIH HHS R37 AI047822NIGMS NIH HHS GM37734NIGMS NIH HHS R01 GM037734NIGMS NIH HHS R37 GM037734
6 · The paper itself

Abstract

The T helper (Th) cell pool is composed of specialized cells with heterogeneous effector functions. Apart from Th1 and 2 cells, CXCR5+ T cells have been suggested to be another type of effector T cell specialized for B cell help. We show here that CXCR5+ T cells are heterogeneous, and we identify subsets of CXCR5+ CD4 T cells that differ in function and microenvironmental localization in secondary lymphoid tissues. CD57+CXCR5 T cells, hereafter termed germinal center Th (GC-Th) cells, are localized only in GCs, lack CCR7, and are highly responsive to the follicular chemokine B lymphocyte chemoattractant but not to the T cell zone EBI1-ligand chemokine. Importantly, GC-Th cells are much more efficient than CD57-CXCR5+ T cells or CXCR5- T cells in inducing antibody production from B cells. Consistent with their function, GC-Th cells produce elevated levels of interleukin 10 upon stimulation which, with other cytokines and costimulatory molecules, may help confer their B cell helper activity. Our results demonstrate that CXCR5+ T cells are functionally heterogeneous and that the GC-Th cells, a small subset of CXCR5+ T cells, are the key helpers for B cell differentiation and antibody production in lymphoid tissues.

Indexed as

Lymphocyte CooperationBiomarkersBloodB-LymphocytesCD57 AntigensCells, CulturedChemokine CCL19Chemokine CXCL13Chemokines, CCChemokines, CXCChemotaxis, LeukocyteChildChild, PreschoolCytokinesGerminal CenterHumansBiomarkersCCL19 protein, humanCD57 AntigensChemokine CCL19Chemokine CXCL13Chemokines, CCChemokines, CXCCXCL13 protein, humanCXCR5 protein, humanCytokinesImmunoglobulinsReceptors, ChemokineReceptors, CXCR5Receptors, Cytokine

Identifiers

PMID11413192
PMCPMC2193300
OpenAlexW2144690750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.